Martin Hartmann

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Evaluation of a didanosin-containing regimen including genotypic resistance testing: an open-label, multicenter study
    Simone Treichel
    University Dep Dermatology, Vossstr 2, D 69115 Heidelberg, Germany
    Eur J Med Res 8:405-13. 2003
  2. ncbi [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz]
    M Hartmann
    Hautklinik, Universitat, Heidelberg
    Hautarzt 56:847-53. 2005
  3. ncbi Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort)
    Martin Hartmann
    Department of Dermatology, University of Heidelberg, Germany
    Int J STD AIDS 16:404-9. 2005
  4. doi Generalized interstitial granuloma annulare--response to adalimumab
    Siegfried Werchau
    Department of Dermatology, University of Heidelberg, Heidelberg, Germany
    Int J Dermatol 49:457-60. 2010
  5. doi Genital mycoplasmas
    Martin Hartmann
    Department of Dermatology, University of Heidelberg, Germany
    J Dtsch Dermatol Ges 7:371-7. 2009
  6. doi Anaphylaxis after mouse bite
    Katharina Leng
    Department of Dermatology, University of Heidelberg, Germany
    J Dtsch Dermatol Ges 6:741-3. 2008
  7. doi Skin diseases and sexually transmitted diseases in HIV-infected patients on HAART compared to a non-infected population - results of a retrospective study
    Sonja Rothengatter
    Department of Dermatology, Heidelberg University Clinic, Germany
    J Dtsch Dermatol Ges 7:527-32. 2009
  8. doi Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses
    Patrick Gholam
    Department of Dermatology, University Heidelberg, Heidelberg, Germany
    J Am Acad Dermatol 63:213-8. 2010
  9. ncbi Residual polymerase activity-induced bias in terminal restriction fragment length polymorphism analysis
    Martin Hartmann
    Molecular Ecology, Agroscope Reckenholz Tanikon Research Station ART, CH 8046 Zurich, Switzerland
    Environ Microbiol 9:555-9. 2007
  10. ncbi [Treatment of erysipelas in Germany and Austria--results of a survey in German and Austrian dermatological clinics]
    Sabine Brennecke
    Universitäts Hautklinik Heidelberg
    J Dtsch Dermatol Ges 3:263-70. 2005

Collaborators

Detail Information

Publications10

  1. ncbi Evaluation of a didanosin-containing regimen including genotypic resistance testing: an open-label, multicenter study
    Simone Treichel
    University Dep Dermatology, Vossstr 2, D 69115 Heidelberg, Germany
    Eur J Med Res 8:405-13. 2003
    ....
  2. ncbi [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz]
    M Hartmann
    Hautklinik, Universitat, Heidelberg
    Hautarzt 56:847-53. 2005
    ..Three patients were re-exposed to the initial drug without any side effects. Therapy with nevirapine or efavirenz does not have to be interrupted if rashes exhibit no blistering, mucosal manifestations, or systemic signs...
  3. ncbi Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort)
    Martin Hartmann
    Department of Dermatology, University of Heidelberg, Germany
    Int J STD AIDS 16:404-9. 2005
    ..In this trial, no difference between EFV and NVP in combination with NRTI backbone therapy can be shown, regarding viral load. Further randomized studies are necessary to evaluate possible differences...
  4. doi Generalized interstitial granuloma annulare--response to adalimumab
    Siegfried Werchau
    Department of Dermatology, University of Heidelberg, Heidelberg, Germany
    Int J Dermatol 49:457-60. 2010
    ..A foreign-body granuloma formation induced by an unknown inciting antigen is suspected. Generalized forms often coincides with recalcitrant progression and frustrated experimental therapies...
  5. doi Genital mycoplasmas
    Martin Hartmann
    Department of Dermatology, University of Heidelberg, Germany
    J Dtsch Dermatol Ges 7:371-7. 2009
    ..Mycoplasma hominis is a cofactor for bacterial vaginosis and pelvic inflammatory disease (PID). During therapy with metronidazole, the colonization of this mycoplasma is decreased indirectly...
  6. doi Anaphylaxis after mouse bite
    Katharina Leng
    Department of Dermatology, University of Heidelberg, Germany
    J Dtsch Dermatol Ges 6:741-3. 2008
    ..Testing revealed positive reactions to all components of the mouse. The greatest risk for development of allergy is in the first three years and is usually an immediate hypersensitivity to inhalant allergens...
  7. doi Skin diseases and sexually transmitted diseases in HIV-infected patients on HAART compared to a non-infected population - results of a retrospective study
    Sonja Rothengatter
    Department of Dermatology, Heidelberg University Clinic, Germany
    J Dtsch Dermatol Ges 7:527-32. 2009
    ..For this reason the spectrum as well as the prevalence of skin diseases has changed. Pathognomonic skin diseases have become rare and the wide spectrum today ranges from infectious to iatrogenic skin diseases...
  8. doi Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses
    Patrick Gholam
    Department of Dermatology, University Heidelberg, Heidelberg, Germany
    J Am Acad Dermatol 63:213-8. 2010
    ..Topical photodynamic therapy is a good treatment option for extensively photodamaged skin with multiple actinic keratoses. Pain is one of the major adverse effects during and after the treatment...
  9. ncbi Residual polymerase activity-induced bias in terminal restriction fragment length polymorphism analysis
    Martin Hartmann
    Molecular Ecology, Agroscope Reckenholz Tanikon Research Station ART, CH 8046 Zurich, Switzerland
    Environ Microbiol 9:555-9. 2007
    ..Efficient removal of polymerases retained original fragment sizes and significantly reduced this profiling bias in soil bacterial communities...
  10. ncbi [Treatment of erysipelas in Germany and Austria--results of a survey in German and Austrian dermatological clinics]
    Sabine Brennecke
    Universitäts Hautklinik Heidelberg
    J Dtsch Dermatol Ges 3:263-70. 2005
    ..The infection is restricted to the dermis and subcutaneous tissues. Treatment with antibiotics is essential. Many different therapeutic regimens are recommended, based mainly on empirical data and only partly proven by clinical studies...